{"id":"https://openalex.org/W2589020344","doi":"https://doi.org/10.1093/annonc/mdw332.42","title":"A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival","display_name":"A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival","publication_year":2016,"publication_date":"2016-09-01","ids":{"openalex":"https://openalex.org/W2589020344","doi":"https://doi.org/10.1093/annonc/mdw332.42","mag":"2589020344"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdw332.42","doi":"https://doi.org/10.1093/annonc/mdw332.42","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdw332.42","pdf_url":"https://academic.oup.com/annonc/article-pdf/27/suppl_4/iv15/19455065/mdw332.42.pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/annonc/article-pdf/27/suppl_4/iv15/19455065/mdw332.42.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091893637","display_name":"Concetta Sergi","orcid":"https://orcid.org/0000-0003-0814-3148","observed_orcids":["https://orcid.org/0000-0003-0814-3148"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Sergi","raw_affiliation_strings":["ARNAS Garibaldi Nesima, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Nesima, Catania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065350055","display_name":"Oriana Commendatore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"O. Commendatore","raw_affiliation_strings":["ARNAS Garibaldi Nesima Oncologia Medica, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Nesima Oncologia Medica, Catania","institution_ids":["https://openalex.org/I4210105999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109918338","display_name":"Giovanni Burrafato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Burrafato","raw_affiliation_strings":["ARNAS Garibaldi Nesima Oncologia Medica, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Nesima Oncologia Medica, Catania","institution_ids":["https://openalex.org/I4210105999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069349157","display_name":"Concetta Martines","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C. Martines","raw_affiliation_strings":["ARNAS Garibaldi Nesima Oncologia Medica, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Nesima Oncologia Medica, Catania","institution_ids":["https://openalex.org/I4210105999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070667772","display_name":"Sebastiano Fabio Garozzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Garozzo","raw_affiliation_strings":["ARNAS Garibaldi Catania Patologia Clinica e Biologia Molecolare, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Catania Patologia Clinica e Biologia Molecolare, Catania","institution_ids":["https://openalex.org/I4210105999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017713944","display_name":"Stefano Sergio Cordio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Cordio","raw_affiliation_strings":["ARNAS Garibaldi Catania Oncologia Medica, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Catania Oncologia Medica, Catania","institution_ids":["https://openalex.org/I4210105999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047365004","display_name":"Daniela Sambataro","orcid":"https://orcid.org/0009-0008-3909-9833","observed_orcids":["https://orcid.org/0009-0008-3909-9833"]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"D. Sambataro","raw_affiliation_strings":["ARNAS Garibaldi Catania Oncologia Medica, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Catania Oncologia Medica, Catania","institution_ids":["https://openalex.org/I4210105999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078934559","display_name":"Diana Cin\u00e0","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"D. Cin\u00e0","raw_affiliation_strings":["ARNAS Garibaldi Catania Patologia Clinica e Biologia Molecolare, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Catania Patologia Clinica e Biologia Molecolare, Catania","institution_ids":["https://openalex.org/I4210105999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021069570","display_name":"S. Miraponte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Miraponte","raw_affiliation_strings":["ARNAS Garibaldi Catania Patologia Clinica e Biologia Molecolare, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Catania Patologia Clinica e Biologia Molecolare, Catania","institution_ids":["https://openalex.org/I4210105999"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008135397","display_name":"Roberto Bordonaro","orcid":"https://orcid.org/0000-0001-5005-0880","observed_orcids":["https://orcid.org/0000-0001-5005-0880"]},"institutions":[{"id":"https://openalex.org/I4210105999","display_name":"Ospedale Garibaldi","ror":"https://ror.org/01q6hrg49","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210105999"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R. Bordonaro","raw_affiliation_strings":["ARNAS Garibaldi Catania Oncologia Medica, Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARNAS Garibaldi Catania Oncologia Medica, Catania","institution_ids":["https://openalex.org/I4210105999"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.25914945,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":null,"first_page":"iv15","last_page":"iv15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.890999972820282},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.8880000114440918},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/post-progression-survival","display_name":"post-progression survival","score":0.8899999856948853},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.9580000042915344},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.6309999823570251},{"id":"https://openalex.org/keywords/outcome-analysis","display_name":"outcome analysis","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9486522674560547},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7397008538246155},{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.7257089614868164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7090818881988525},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.630521833896637},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5819705128669739},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5721205472946167},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.4660799205303192},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.4654114544391632},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4246363639831543},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41500675678253174},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.41283735632896423},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36447954177856445},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3312914967536926},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.24152454733848572},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdw332.42","doi":"https://doi.org/10.1093/annonc/mdw332.42","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdw332.42","pdf_url":"https://academic.oup.com/annonc/article-pdf/27/suppl_4/iv15/19455065/mdw332.42.pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdw332.42","doi":"https://doi.org/10.1093/annonc/mdw332.42","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdw332.42","pdf_url":"https://academic.oup.com/annonc/article-pdf/27/suppl_4/iv15/19455065/mdw332.42.pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2589020344.pdf","grobid_xml":"https://content.openalex.org/works/W2589020344.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2098644433","https://openalex.org/W2979538676","https://openalex.org/W3012421737","https://openalex.org/W2886195912","https://openalex.org/W2890060502","https://openalex.org/W2275952218","https://openalex.org/W3162262984","https://openalex.org/W2273375516","https://openalex.org/W1914354634","https://openalex.org/W2898248998"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-02-24T00:00:00"}